Angiogenesis inhibitors derived from thalidomide

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 24, 2005, Pages 5509-5513

  Noguchi, Tomomi ^a   Fujimoto, Haruka ^a   Sano, Hiroko ^a   Miyajima, Atsushi ^a   Miyachi, Hiroyuki ^a   Hashimoto, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; HUVEC; Phthalimide; Structural development; Thalidomide

Indexed keywords

5 HYDROXY 2 (2,6 DIISOPROPYLPHENYL) 1H ISOINDOLE 1,3 DIONE; 5 HYDROXYTHALIDOMIDE; ANGIOGENESIS INHIBITOR; DRUG METABOLITE; HYDROXYL GROUP; IMMUNOMODULATING AGENT; ISOINDOLE DERIVATIVE; THALIDOMIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; ENDOTHELIUM, VASCULAR; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; THALIDOMIDE; UMBILICAL VEINS;

EID: 27644582508     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.08.086     Document Type: Article

References (29)

1. B.F. Hales Nat. Med. 5 1999 489
2. Y. Hashimoto Curr. Med. Chem. 5 1998 163
3. L. Calbrese, and A.B. Fleisher Am. J. Med. 108 2000 487
4. J.B. Bartlett, K. Dredge, and A.G. Dalglish Nat. Rev. Cancer 4 2004 314
5. P. Richardson, T. Hideshima, and K. Anderson Annu. Rev. Med. 53 2002 629
6. E.P. Sampaio, G. Kaplan, A. Miranda, J.A.C. Nery, C.P. Miguel, S.M. Viana, and E.N. Sarno J. Infect. Dis. 168 1993 408
7. R.J. D' Amato, M.S. Loughnan, E. Flynn, and J. Folkman Proc. Natl. Acad. Sci. U.S.A. 91 1994 4082
8. K.S. Bauer, S.C. Dixon, and W.D. Figg Biochem. Pharmacol. 55 1998 1827
9. H. Miyachi, A. Azuma, A. Ogasawara, E. Uchimura, N. Watanabe, Y. Kobayashi, F. Kato, M. Kato, and Y. Hashimoto J. Med. Chem. 40 1997 2858
10. G.W. Muller, R. Chen, S.-Y. Huang, L.G. Corral, L.M. Wong, R.T. Patterson, Y. Chen, G. Kaplan, and D.I. Stirling Bioorg. Med. Chem. Lett. 9 1999 1625
11. T. Noguchi, C. Shinji, H. Kobayashi, M. Makishima, H. Miyachi, and Y. Hashimoto Biol. Pharm. Bull. 28 2005 563
12. S. Inatsuki, T. Noguchi, H. Miyachi, S. Oda, T. Iguchi, M. Kizaki, Y. Hashimoto, and H. kobayashi Bioorg. Med. Chem. Lett. 15 2005 321
13. 2O: C, 76.40; H, 7.91; N, 8.91. Found: C, 76.12; H, 7.78; N, 8.60.
14. 3: C, 70.99; H, 6.55; N, 8.28. Found: C, 71.02; H, 6.58; N, 8.17.
15. H. Miyachi, A. Ogasawara, A. Azuma, and Y. Hashimoto Bioorg. Med. Chem. 5 1997 2095
16. S.S.W. Ng, M. Gutschow, M. Weiss, S. Hauschildt, U. Teubert, T.K. Hecker, F.A. Luzzio, E.A. Kruger, K. Eger, and W.D. Figg Cancer Res. 63 2003 3189
17. H. Miyachi, A. Azuma, T. Kitamoto, K. Hayashi, S. Kato, M. Koga, B. Sato, and Y. Hashimoto Bioorg. Med. Chem. Lett. 7 1997 1483
18. T. Ishioka, A. Kubo, Y. Koiso, K. Nagasawa, A. Itai, and Y. Hashimoto Bioorg. Med. Chem. 10 2002 1555
19. T. Ishioka, A. Tanatani, K. Nagasawa, and Y. Hashimoto Bioorg. Med. Chem. Lett. 13 2003 2655
20. M. Komoda, H. Kakuta, H. Takahashi, F. Yasuyuki, K. Shizuo, F. Kato, and Y. Hashimoto Bioorg. Med. Chem. 9 2001 121
21. H. Kakuta, H. Takahashi, S. Sou, T. Kita, K. Nagasawa, and Y. Hashimoto Recent Res. Dev. Med. Chem. 1 2001 189
22. R. Shimazawa, H. Takayama, Y. Fujimoto, M. Komoda, K. Dodo, R. Yamasaki, R. Shirai, Y. Koiso, K. Miyata, F. Kato, M. Kato, H. Miyachi, and Y. Hashimoto J. Enzym. Inhib. 14 1999 259
23. S. Sou, S. Mayumi, H. Takahashim, R. Yamasaki, S. Kadoya, M. Sodeoka, and Y. Hashimoto Bioorg. Med. Chem. Lett. 10 2000 1081
24. S. Sou, H. Takahashi, R. Yamasaki, H. Kagechika, Y. Endo, and Y. Hashimoto Chem. Pharm. Bull. 49 2001 791
25. T. Kita, H. Takahashi, and Y. Hashimoto Biol. Pharm. Bull. 24 2001 860
26. T. Noguchi, R. Shimazawa, K. Nagasawa, and Y. Hashimoto Bioorg. Med. Chem. Lett. 12 2002 1043
27. H. Sano, T. Noguchi, A. Tanatani, H. Miyachi, and Y. Hashimoto Chem. Pharm. Bull. 52 2004 1021
28. R. Shimazawa, H. Sano, A. Tanatani, H. Miyachi, and Y. Hashimoto Chem. Pharm. Bull. 52 2004 498
29. T. Noguchi, H. Sano, R. Shimazawa, A. Tanatani, H. Miyachi, and Y. Hashimoto Bioorg. Med. Chem. Lett. 14 2004 4141